ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物醫藥B類股
708.812
-7.154
-1.00%
手動刷新
漲家數:
5
跌家數:
25
平家數:
4
市盈率:
- -
高:
728.504
開:
715.966
低:
707.752
收:
715.966
成交量:
4,332.28萬
成交額:
16.19億
市值:
4,538.88億
流通市值:
4,029.14億
資料載入中...
總覽
新聞資訊
三大指數齊漲 創新藥領升 石油股走低丨港股午評
21世纪经济报道
·
04/15
午評:滬指半日漲0.37% 醫藥商業板塊走強
中金财经
·
04/15
業績透視之滬企領航|科創板創新藥企引領出海趨勢
证券日报
·
04/15
歸創通橋(02190)股價上升5.209%,現價港幣$24.64
阿斯达克财经
·
04/15
醫藥板塊持續走強
第一财经
·
04/15
工信部:正編制醫藥工業「十五五」發展規劃 推動優質優價藥品早日上市供應
阿斯达克财经
·
04/15
工信部:合力支持創新藥早日生產、早日上市、早日進醫院
格隆汇
·
04/15
國家醫保局:累計將199種創新藥納入到醫保報銷範圍
金融一线
·
04/15
港股異動 | 創新藥概念股上漲,勁方醫藥升逾9%!國辦發文健全藥價形成機制,花旗研報稱創新藥企有望受益
智通财经
·
04/15
國辦9號文正式發布,利好醫藥創新!華寶基金港股通創新藥ETF(520880)、港股通醫療ETF攜手漲逾2.5%!
新浪基金
·
04/15
醫藥早參|藥品價格機制新政出台,創新藥發展環境持續優化
每日经济新闻
·
04/15
定價權迴歸市場!創新藥迎重大政策利好 最新高增長潛力股名單出爐
市场资讯
·
04/15
基石藥業-B(02616)擬配售合共1.18億股配售股份 淨籌約10.53億港元
智通财经
·
04/15
港股概念追蹤 | 創新藥板塊迎政策東風 國辦發文健全藥品價格形成機制(附概念股)
智通财经
·
04/15
政策加碼我國創新藥實現 自研與出海雙突破
经济参考报
·
04/15
優必選認知功能評估與訓練軟件Cogdo S4獲醫療器械註冊證
人民财讯
·
04/14
創新藥賽道午後回暖,資金連續4個交易日佈局港股通創新藥ETF易方達(159316)
中金财经
·
04/14
創新藥「加速度」,商保角色重塑:從補充支付到核心參與!
市场资讯
·
04/14
君實生物在珠海成立新醫藥科技公司 註冊資本5000萬元
证券日报
·
04/14
國辦:對創新程度高、臨床價值大的高水平創新藥 支持在上市初期制定與高投入、高風險相符的價格
滚动播报
·
04/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":708.81165,"timestamp":1776395846899,"preClose":715.96594,"halted":0,"volume":43322780,"delay":0,"changeRate":-0.009993,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-7.154297,"latestTime":"04-17 11:17:28","open":715.96594,"high":728.5041,"low":707.7522,"amount":1619419859,"amplitude":0.028984,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1776398400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"pbRate":5.627353,"peRate":-94.073273,"turnoverRate":0.00158,"increases":5,"decrements":25,"flats":3,"marketCap":453888179904,"floatMarketCap":402914107216},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":728.5041,"amplitude":0.028984,"preClose":715.96594,"low":707.7522,"pbRate":"5.627353","latestPrice":708.81165,"volume":43322780,"delay":0,"open":715.96594,"prevYearClose":556.26263,"prevWeekClose":666.249,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":666.249,"twentyDayClose":575.488,"sixtyDayClose":612.872,"secType":"PLATE","market":"HK","turnoverRate":0.00158,"peRate":-94.073273,"marketCap":453888179904,"floatMarketCap":402914107216,"timestamp":1776395846899,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":5,"down":25,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627994470","title":"三大指數齊漲 創新藥領升 石油股走低丨港股午評","url":"https://stock-news.laohu8.com/highlight/detail?id=2627994470","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627994470?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 12:40","pubTimestamp":1776228000,"startTime":"0","endTime":"0","summary":"港股早盘三大指数齐涨,恒指涨0.76%,国指涨0.87%,恒生科技指数涨1.88%。创新药概念领涨,轩竹生物-B涨超12%,劲方医药-B、荣昌生物等跟涨。消息面上,诺和诺德宣布与OpenAI建立战略合作伙伴关系,此次合作将运用先进的人工智能能力分析复杂数据集,筛选具有潜力的候选药物,并缩短从基础研究到惠及患者所需的时间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705709370.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705709370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XOP","VDE","USOI","USE","PXJ","DBC","BK4588","DRLL","USL","06978","OIH","DBE","OILT","OILU","BK4570","DRIP","BK1161","ERX","XLE","IXC","VXUS","GUSH","159992","BK1574","IEO","BK4585","BNO","DIG","OILK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627847053","title":"午評:滬指半日漲0.37% 醫藥商業板塊走強","url":"https://stock-news.laohu8.com/highlight/detail?id=2627847053","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627847053?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 12:39","pubTimestamp":1776227943,"startTime":"0","endTime":"0","summary":"中国经济网北京4月15日讯 A股三大指数今日早盘涨跌互现,截至午间收盘,上证综指报4041.45点,涨幅0.37%;深证成指报14603.61点,跌幅0.25%;创业板指报3550.25点,跌幅0.23%。\r\n\r\n 板块方面,医药商业、中药、黑色家电等板块涨幅居前,能源金属、油气开采及服务、房地产等板块跌幅居前。\r\n\r\n A股市场板块涨跌幅排行\r\n\r\n \r\n\r\n \r\n\r\n \r\n\r\n (责任编辑:马欣)","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/15/20260415125840.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/15/20260415125840.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260415/32144822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159967","000905.SH","000001","512880","BK1574","BK1515","515890","510880","510300","BK1161","000300.SH","000688.SH","399006","399001","512510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627477786","title":"業績透視之滬企領航|科創板創新藥企引領出海趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2627477786","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627477786?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 11:50","pubTimestamp":1776225000,"startTime":"0","endTime":"0","summary":"本报讯(记者毛艺融)近期,科创板生物医药企业进入年报密集披露期。4月14日,百济神州有限公司(以下简称“百济神州”)提交2025年年报,在实现业绩稳健增长的同时扭亏为盈,即将摘“U”出层。这份“十四五”收官的业绩答卷,不仅展现了创新药企的成果兑现能力,更揭开了科创板医药企业面向“十五五”的出海新谋划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705697124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","06978","159992","BK1161","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627648477","title":"歸創通橋(02190)股價上升5.209%,現價港幣$24.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2627648477","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627648477?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 11:49","pubTimestamp":1776224940,"startTime":"0","endTime":"0","summary":"[上升股]归创通桥(02190) 股价在上午11:49比前收市价上升5.209%,现股价为港币$24.64。至目前为止,今日最高价为$24.64,而最低价为$23.12。总成交量为153.141万股,总成交金额为港币$3.623千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2604153292/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2604153292/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","02190","BK1587","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627775764","title":"醫藥板塊持續走強","url":"https://stock-news.laohu8.com/highlight/detail?id=2627775764","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627775764?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 11:31","pubTimestamp":1776223860,"startTime":"0","endTime":"0","summary":"瑞康医药、金陵药业、海正药业、鹭燕医药此前涨停,华人健康涨逾16%,北大医药、东诚药业、热景生物、人民同泰跟涨。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-04-15/doc-inhupzny4147909.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-15/doc-inhupzny4147909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","09939","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627729554","title":"工信部:正編制醫藥工業「十五五」發展規劃 推動優質優價藥品早日上市供應","url":"https://stock-news.laohu8.com/highlight/detail?id=2627729554","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627729554?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 11:30","pubTimestamp":1776223800,"startTime":"0","endTime":"0","summary":"工业和信息化部消费品工业司司长何亚琼在国务院政策例行吹风会上表示,正在编制《医药工业“十五五”发展规划》。下一步将重点做好“四个加快”,包括加快打造“创新医药”、“普惠医药”、“数智医药”及“开放医药”。何亚琼指,提质和降价不是零和博弈,希望研发单位及生产企业,力争做到薄利多销,抢抓产业发展机遇,加快人工智能技术的融合应用,在质量及价格与可及性方面实现平衡,推动更多优质优价的医药产品早日上市供应。(ta/da)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180202161550760_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180202161550760_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1517748/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1517748/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","09939","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627474051","title":"工信部:合力支持創新藥早日生產、早日上市、早日進醫院","url":"https://stock-news.laohu8.com/highlight/detail?id=2627474051","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627474051?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 11:24","pubTimestamp":1776223460,"startTime":"0","endTime":"0","summary":"加快打造“创新医药”","market":"sh","thumbnail":"https://img3.gelonghui.com/29897-ff22031f-3416-42cd-98e0-32887c7aa576.jpg?guru_height=3264&guru_width=5824&guru_size=1378769","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/29897-ff22031f-3416-42cd-98e0-32887c7aa576.jpg?guru_height=3264&guru_width=5824&guru_size=1378769"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4417070","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["06978","BK1574","159992","IPOS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627474344","title":"國家醫保局:累計將199種創新藥納入到醫保報銷範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2627474344","media":"金融一线","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627474344?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 10:54","pubTimestamp":1776221640,"startTime":"0","endTime":"0","summary":"4月15日金融一线消息,国新办今日上午举行国务院政策例行吹风会,国家医保局医药价格和招标采购司司长王小宁表示,国家医保局始终旗帜鲜明支持医药创新,连续8年开展了医保目录谈判,累计将199种创新药纳入到医保报销范围。医保基金战略性购买为促进创新药发展发挥了关键性作用,截至今年2月份,医保基金累计为协议期内谈判药品支出5048亿元,带动销售7400亿元,惠及11.7亿人次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-04-15/doc-inhupvfk3645243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","06978","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627479216","title":"港股異動 | 創新藥概念股上漲,勁方醫藥升逾9%!國辦發文健全藥價形成機制,花旗研報稱創新藥企有望受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2627479216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627479216?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 10:21","pubTimestamp":1776219660,"startTime":"0","endTime":"0","summary":"4月15日,创新药概念股上涨,$劲方医药-B$涨超9%,$信达生物$涨超4%,$恒瑞医药$、$石药集团$跟涨。重点创新药企/生物制药公司将成为受益者,如$恒瑞医药$、石药集团、信达生物以及其他跨国公司。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428631.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"港股异动 | 创新药概念股上涨,劲方医药涨超9%!国办发文健全药价形成机制,花旗指恒瑞等创新药企有望受益","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4566","LU2097828631.EUR","IE0008368742.USD","BK1574","LU2456880835.USD","LU2097828557.USD","IE00B543WZ88.USD","LU1813983027.USD","LU2097828805.USD","LU0315179316.USD","IE0008369823.USD","BK4588","BK4534","LU1807302812.USD","LU0128525689.USD","LU0098860793.USD","LU2125154778.USD","BK4504","LU0314109678.HKD","LU0980610538.SGD","LU1226288253.USD","BK1521","LU0359201612.USD","LU0072913022.USD","LU1244550494.USD","LU0359202008.SGD","LU0648001328.SGD","LU2417539215.USD","LU2039709279.SGD","SG9999004220.SGD","LU2097828714.EUR","LU1969619763.USD","02595","LU1152091754.HKD","LU0314106906.USD","IE00BSNM7G36.USD","LU1008478684.HKD","LU2328871848.SGD","LU0880133367.SGD","LU2462157665.USD","LU1226287792.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627471345","title":"國辦9號文正式發布,利好醫藥創新!華寶基金港股通創新藥ETF(520880)、港股通醫療ETF攜手漲逾2.5%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2627471345","media":"新浪基金","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627471345?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 10:11","pubTimestamp":1776219060,"startTime":"0","endTime":"0","summary":"重磅政策利好来袭,4月15日早盘,港股医药强劲反弹!100%创新药研发标的——港股通创新药ETF华宝一度冲上3%,现涨2.5%,权重龙头集体拉涨,信达生物涨超4%,百济神州、中国生物制药涨超3%。 港股医疗同步活跃,场内热门港股通医疗ETF华宝放量涨2.59%冲击连阳,权重股晶泰控股劲涨6%,京东健康涨4%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-15/doc-inhupvfa4217667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","159938","BK1574","BK1161","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627479134","title":"醫藥早參|藥品價格機制新政出台,創新藥發展環境持續優化","url":"https://stock-news.laohu8.com/highlight/detail?id=2627479134","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627479134?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 09:41","pubTimestamp":1776217266,"startTime":"0","endTime":"0","summary":"4月14日,港股通生物科技ETF华安(159102)上涨0.61%。成分股中,药明生物上涨5.50%、药明康德上涨1.25%、信达生物下跌0.69%、百济神州下跌1.18%。与此同时,医药ETF华安(512120)上涨0.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705568062.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705568062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159992","09939","BK1515","06978","159938","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627730054","title":"定價權迴歸市場!創新藥迎重大政策利好 最新高增長潛力股名單出爐","url":"https://stock-news.laohu8.com/highlight/detail?id=2627730054","media":"市场资讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627730054?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 07:46","pubTimestamp":1776210360,"startTime":"0","endTime":"0","summary":"时隔11年,国家层面再次以国务院办公厅名义就药品价格议题发布纲领性文件,标志我国从“分散控费”转向全生命周期、分类施策、全国统一市场的价格治理新阶段。 4月14日,国务院办公厅印发《关于健全药品价格形成机制的若干意见》,提出14条举措,包括优化创新药等新上市药品首发价格机制、发挥医保支付标准对药品价格形成的引导作用、引导药店合理制定药品零售价格、强化短缺药保供稳价等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-04-15/doc-inhupqxi8554462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","159992","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627342004","title":"基石藥業-B(02616)擬配售合共1.18億股配售股份 淨籌約10.53億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627342004","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627342004?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 07:28","pubTimestamp":1776209318,"startTime":"0","endTime":"0","summary":"智通财经APP讯,基石药业-B 发布公告,于2026年4月14日,本公司与配售代理订立配售协议,本公司已有条件同意透过配售代理,以每股配售股份8.97港元的价格,向不少于六名承配人配售合共1.18亿股配售股份。配售股份将根据一般授权配发及发行,且无需取得任何股东批准。假设所有1.18亿股配售股份获悉数认购,于配售完成后,配售所得款项总额将为10.58亿港元,配售所得款项净额估计为10.53亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627245420","title":"港股概念追蹤 | 創新藥板塊迎政策東風 國辦發文健全藥品價格形成機制(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627245420","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627245420?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 07:16","pubTimestamp":1776208598,"startTime":"0","endTime":"0","summary":"意见从4个方面提出14条举措,包括完善重点环节药品价格政策、推动相关主体发挥药品价格发现作用、引导关键领域药品价格保持合理水平、加强药品价格治理。具体举措包括优化创新药等新上市药品首发价格机制、发挥医保支付标准对药品价格形成的引导作用、健全药品集中带量采购价格形成机制、完善药品挂网价格管理。《意见》发布后,市场普遍认为新政将为医药产业特别是创新药带来发展新契机。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572944931.SGD","LU1242518931.SGD","LU0181495838.USD","LU0516422366.SGD","LU0979878070.USD","BK4585","IE00B0JY6N72.USD","LU0051755006.USD","LU0140636845.USD","LU2045819591.USD","LU2242644610.SGD","SG9999002463.SGD","03347","LU0348735423.USD","LU0320764599.SGD","LU0043850808.USD","LU0348825331.USD","LU0326950275.SGD","LU0417516902.SGD","LU0856984785.SGD","BK1574","LU1046422090.SGD","BK1161","BK1589","BK1583","LU1242518857.USD","LU0052750758.USD","06127","02315","LU0039217434.USD","LU0456827905.SGD","LU0516423091.SGD","159992","LU2039709279.SGD","LU0823426308.USD","BK1141","02359","02269","LU0516422952.EUR","06978","LU0516422440.USD","VXUS","LU0359202008.SGD","LU0588546209.SGD","LU0819121731.USD","LU0327786744.USD","LU0307460666.USD","LU0708995583.HKD","BK1610","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627042403","title":"政策加碼我國創新藥實現 自研與出海雙突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2627042403","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627042403?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 04:41","pubTimestamp":1776199312,"startTime":"0","endTime":"0","summary":"国务院办公厅近日印发《关于健全药品价格形成机制的若干意见》(以下简称《意见》)。多位业内人士表示,《意见》提出的全生命周期药品价格形成机制,为我国创新药产业发展筑牢了政策根基,不仅规范了药品定价秩序,更稳定了企业创新投入预期,为行业有序竞争、长期可持续发展注入强劲动力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153704971265.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153704971265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","159992","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627441633","title":"優必選認知功能評估與訓練軟件Cogdo S4獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2627441633","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627441633?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 20:48","pubTimestamp":1776170880,"startTime":"0","endTime":"0","summary":"人民财讯4月14日电,据优必选消息,近日,优必选认知功能评估与训练软件CogdoS4获医疗器械注册证,正式成为具备临床准入资质的数字疗法产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604143704696691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK4588","BK1222","09880","BK1100","BK1583","BK1183","BK1613","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627434024","title":"創新藥賽道午後回暖,資金連續4個交易日佈局港股通創新藥ETF易方達(159316)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627434024","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627434024?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 19:43","pubTimestamp":1776167023,"startTime":"0","endTime":"0","summary":"4月14日,创新药赛道午后回暖,指数层面,恒生港股通创新药指数上涨0.3%,中证创新药产业指数上涨0.7%,港股通创新药ETF易方达全天获3100万份净申购。Wind数据显示,该ETF此前已连续3个交易日获资金净流入,合计9000万元。兴业证券表示,中国创新药具备高效率、低成本的开发优势,在热门技术赛道如 ADC、双抗、小核酸等具备竞争优势,有望持续展现行业竞争力。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/14/20260414741546.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/14/20260414741546.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260414/32143378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159316","BK1161","BK1574","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627458354","title":"創新藥「加速度」,商保角色重塑:從補充支付到核心參與!","url":"https://stock-news.laohu8.com/highlight/detail?id=2627458354","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627458354?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 19:31","pubTimestamp":1776166260,"startTime":"0","endTime":"0","summary":" 在我国多层次医疗保障体系持续深化完善、医药创新产业迈向高质量发展的关键阶段,商业健康险的行业定位正发生根本性转变。这是国办文件中首次如此明确且系统地将商业健康险置于创新药支付体系的核心位置,标志着商保参与医药创新的制度框架全面成型。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/bxdt/2026-04-14/doc-inhunpmu1494189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","159992","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627486614","title":"君實生物在珠海成立新醫藥科技公司 註冊資本5000萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627486614","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627486614?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 18:46","pubTimestamp":1776163560,"startTime":"0","endTime":"0","summary":"本报讯天眼查App显示,近日,珠海君实生物医药科技有限公司成立,注册资本5000万元,经营范围包括医学研究和试验发展、技术进出口、货物进出口等,由君实生物全资持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604143704576637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1515","159938","01877","BK1574","BK1161","688180","BK0239","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627411595","title":"國辦:對創新程度高、臨床價值大的高水平創新藥 支持在上市初期制定與高投入、高風險相符的價格","url":"https://stock-news.laohu8.com/highlight/detail?id=2627411595","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627411595?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 17:03","pubTimestamp":1776157380,"startTime":"0","endTime":"0","summary":" 4月14日,国务院办公厅发布关于健全药品价格形成机制的若干意见。对创新程度高、临床价值大的高水平创新药,支持在上市初期制定与高投入、高风险相符的价格,在一定时期内保持价格相对稳定。对改良新药等,鼓励引导制定与患者获益相匹配的价格。对通用名药等其他新上市药品,引导医药企业参照同通用名、同作用机制、同功能主治药品价格合理定价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-04-14/doc-inhunicu4772129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","IPOS","06978","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":4,"totalSize":241,"code":"91000000","status":"200"}]}}